IP Verse

Revitope Limited opposition analysis

COMPANY ANALYSIS

Patent Number:

Title:

Dual Antigen-Induced Bipartite Functional Complementation

Applicant:

Opposition Date:

Jul 3, 2018

Patent:

Grant Date:

Mar 17, 2021

Title:

Functional Antibody Fragment Complementation For A Two-Components System For Redirected Killing Of Unwanted Cells

Oppositions:

Patent Number	Title	Applicant	Opposition Date
EP2802607	Dual Antigen-Induced Bipartite Functional Complementation	JULIUS-MAXIMILIANS-UNIVERSITÄT WÜRZBURG	Jul 3, 2018

Patent Number	Grant Date	Title	Total Oppositions
EP3377103	Mar 17, 2021	Functional Antibody Fragment Complementation For A Two-Components System For Redirected Killing Of Unwanted Cells	2

CHERRY BIOLABS GMBH

JULIUS-MAXIMILIANS-UNIVERSITÄT WÜRZBURG

TAKEDA PHARMACEUTICAL COMPANY LIMITED

Feel free to send us a message here and we will get back to you